We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
11 hedge funds and large institutions have $109K invested in Windtree Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
175% more funds holding
Funds holding: 4 → 11 (+7)
0.13% less ownership
Funds ownership: 0.2% → 0.07% (-0.13%)
72% less capital invested
Capital invested by funds: $390K → $109K (-$281K)
Holders
11
Holders Change
+7
Holders Change %
+175%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$75.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$37.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.5K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$12.3K |
| 5 |
Two Sigma Investments
New York
|
+$9.17K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$375K |
| 2 |
Morgan Stanley
New York
|
-$8.87K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$2 |